You are here:
NICE
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Bortezomib monotherapy for relapsed multiple myeloma
Technology appraisal guidance
Reference number:
TA129
Published:
23 October 2007
Guidance
Tools and resources
Information for the public
History
Download guidance (PDF)
Overview
1 Guidance
2 The technology
3 The manufacturer's submission
4 Consideration of the evidence
5 Implementation
6 Recommendations for further research
7 Related NICE guidance
8 Review of guidance
Appendix A: Appraisal Committee members and NICE project team
Appendix B: Sources of evidence considered by the Committee
Changes after publication
About this guidance
7 Related NICE guidance
7.1
There is no related guidance for this technology.
Next page
8 Review of guidance
Previous page
6 Recommendations for further research